Aneurysmal subarachnoid hemorrhage is an acute cerebrovascular disease with high disability and mortality. We intended to explore the association between levels of erythrocytes in cerebrospinal fluid at different times of hemorrhage and the outcome of patients. One retrospective study including 216 patients with aneurysmal subarachnoid hemorrhage undergoing surgeries in the First Affiliated Hospital of Yangtze University from January 2020 to July 2023 was carried. The univariable analysis and multivariable logistic regression analysis were used for factors associated with poor outcome. The level of erythrocytes in cerebrospinal fluid on the 1st postoperative day in patients with poor outcome was 311 × 103/µL, significantly higher than patients with good outcome (108 × 103/µL), P < .001. The level of erythrocytes in cerebrospinal fluid on 7th postoperative day was 86.5 × 103/µL, also significantly higher than patients with good outcome (26.0 × 103/µL). The multivariable logistic regression analysis results showed that erythrocytes in cerebrospinal fluid on the 1st postoperative day (≥177 × 103/µL) and on the 7th postoperative day (≥53.5 × 103/µL) were possibly associated with poor outcome in aneurysmal subarachnoid hemorrhage patients. Treatment with tranexamic acid and continuous lumbar drainage did not result in a decrease of erythrocytes in cerebrospinal fluid. Higher erythrocytes in cerebrospinal fluid on the 1st and 7th postoperative days were associated with poor outcome in aneurysmal subarachnoid hemorrhage patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11479430PMC
http://dx.doi.org/10.1097/MD.0000000000040027DOI Listing

Publication Analysis

Top Keywords

erythrocytes cerebrospinal
12
cerebrospinal fluid
12
poor outcome
12
aneurysmal subarachnoid
12
subarachnoid hemorrhage
12
postoperative day
8
associated poor
8
patients aneurysmal
8
outcome
5
patients
5

Similar Publications

Article Synopsis
  • The study examined the clinical features and prognosis of neuro-Behçet's syndrome (NBS) in 5 children, analyzing their medical data over a span of 10 years from various pediatric departments.
  • The patients, aged between 8 to 17 years, exhibited variable symptoms like headaches, convulsions, and impaired motor functions; some showed no symptoms, highlighting the non-specific nature of NBS.
  • Treatment involved corticosteroids alongside immunosuppressants, resulting in positive outcomes for most patients, although one individual discontinued treatment; imaging showed diverse brain lesions not easily identifiable as NBS.
View Article and Find Full Text PDF

Cerebrospinal Fluid Cytology in Lyme Neuroborreliosis Revisited-Role of Neutrophilic Granulocytes: A Retrospective Single-Center Study.

J Clin Med

December 2024

Department of Neurology, Christian-Doppler University Hospital, Paracelsus Medical University, Centre for Cognitive Neuroscience, Ignaz Harrer Str. 79, 5020 Salzburg, Austria.

: diagnosis of Lyme neuroborreliosis (LNB) relies on medical history, clinical findings, and detection of pathogen-specific antibodies in the blood and cerebrospinal fluid (CSF). The chemoattractant CXCL13 serves as an additional marker for LNB acuity. During the diagnostic workup, cytomorphological examination of immune cells in CSF provides early insights.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on meningoencephalitis, which involves both meningitis and encephalitis, aiming to analyze the clinical features, lab tests, imaging results, and factors predicting outcomes in affected patients.
  • Conducted from July 2021 to March 2023, it enrolled patients who met the case definitions for meningitis and encephalitis, tracking their mortality and health recovery over one and three months post-discharge.
  • Out of 102 cases, various infectious and non-infectious causes were identified, with notable findings in cerebrospinal fluid analysis and imaging; particularly, high mortality rates were seen in fungal and rickettsial cases while patient recovery varied depending on the type of meningoencephalitis experienced
View Article and Find Full Text PDF

Specific analysis of SOD1 enzymatic activity in CSF from ALS patients with and without SOD1 mutations.

Neurobiol Dis

November 2024

Department of Medical Biosciences, Clinical Chemistry, Umeå University, SE-901 85 Umeå, Sweden. Electronic address:

Mutations in superoxide dismutase-1 (SOD1) are a cause of hereditary amyotrophic lateral sclerosis (ALS) through a gain-of-function mechanism involving unfolded mutant SOD1. Intrathecal gene therapy using the antisense-oligo-nucleotide drug tofersen to reduce SOD1 expression delays disease progression and has recently been approved in the United States and the European Union. However, the discovery of children homozygous for inactivating SOD1 mutations developing the SOD1 Deficiency Syndrome (ISODDES) with injury to the motor system suggests that a too low SOD1 antioxidant activity may be deleterious in humans.

View Article and Find Full Text PDF
Article Synopsis
  • Hemophagocytic lymphohistiocytosis (HLH) is an immune disorder causing severe inflammation, categorized into primary (familial) and secondary (acquired) types; secondary HLH can occur due to various triggers, including infections like Epstein-Barr virus (EBV).
  • A 12-year-old girl with childhood-onset systemic lupus erythematosus (SLE) developed fever, seizures, and altered mental status, raising concerns for neuropsychiatric SLE or infections, leading to extensive testing and treatment.
  • Diagnosis of HLH was confirmed through blood tests showing abnormal cell counts and bone marrow analysis revealing hemophagocytic activity, along with CSF analysis that identified EBV as the
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!